Private Equity Firm Financial Services

Fremman Capital

Luxembourg, England, Luxembourg

Independent Pan-European private equity firm partnering with management teams to invest responsibly and build multinational, sustainable businesses.

Focus Areas
Private equity investing
Website
fremman.com

Tracked deals

11

11 tracked deals across 2021-2025.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Buyout

10 buyout · 1 recapitalization

Fremman Capital Acquisition Volume by Year

Last 4 years

Acquisition volume by year Annual acquisition counts for the last 4 years for Fremman Capital. 4 2021 2 2023 3 2024 2 2025

Supporting Data

Recent Transactions

  • Buyer
    Fremman Capital, Chequers Capital
    Target
    Bertin Technologies group (Bertin Technologies)
    Seller
    FCDE, Management (Bertin Technologies group management team), BNP Paribas Développement
    Location
    France
    Type
    Buyout

    Fremman Capital and Chequers Capital have executed a put option agreement to acquire Bertin Technologies Group, a European advanced instrumentation provider, from its majority shareholder FCDE alongside management and BNP Paribas Développement. The deal is intended to help Bertin accelerate organic growth, improve operational performance, and expand capabilities and international reach, with co-control planned alongside management subject to approvals and consultation with employee representatives.

  • Buyer
    Fremman Capital
    Target
    DIESSE Diagnostica Senese
    Seller
    ARCHIMED (MED II)
    Industry
    Medical Devices
    Location
    Tuscany, Italy
    Type
    Buyout

    Fremman Capital has acquired a majority stake in Italian In Vitro Diagnostics (IVD) company DIESSE Diagnostica Senese from ARCHIMED's MED II. DIESSE, headquartered in Monteriggioni (Siena), Italy, operates a new biotech campus and ~230 employees and will continue to be led by its management team which retains a meaningful minority stake; Fremman plans to further internationalize and grow the business.

  • Buyer
    Fremman Capital
    Target
    rehaneo
    Seller
    Gimv
    Location
    Germany
    Type
    Buyout

    Fremman Capital has agreed to acquire a majority stake in German outpatient rehabilitation group rehaneo from European investment company Gimv. The founders Bruno Crone and Christoph Dühr remain significant shareholders and will continue to run the business; the deal is subject to German antitrust approval and is expected to close in Q1 2025.

  • Buyer
    Fremman Capital
    Target
    connexta GmbH
    Seller
    AURELIUS Wachstumskapital, Management (connexta)
    Industry
    IT Services
    Location
    Bavaria, Germany
    Type
    Buyout

    Fremman Capital has acquired a majority stake in Munich-headquartered IT services platform connexta from AURELIUS Wachstumskapital, with the company's management and sellers remaining as significant minority shareholders. H.I.G. WhiteHorse Europe provided a €90 million debt financing package to support the acquisition and connexta's planned buy-and-build expansion across the German SME market.

  • Buyer
    Fremman Capital
    Target
    Innovative Beauty Group (IBG)
    Seller
    Albéa group
    Location
    France
    Type
    Buyout

    Fremman Capital has executed a put option agreement to acquire Innovative Beauty Group (IBG), a beauty and personal care “turn-key” product development and solutions provider, which is part of the Albéa group. The company offers end-to-end product development including ideation, formulation, filling, packaging, and marketing, supported by a global footprint and 300 employees.

  • Buyer
    Fremman Capital
    Target
    HT Médica
    Seller
    Luna family
    Location
    Spain
    Type
    Buyout

    Fremman Capital has acquired a majority stake in HT Médica, a leading Spanish provider of radiology and diagnostic imaging services, partnering with the Luna family to support the company's next stage of growth. Fremman will help HT Médica expand its reach, implement technology and drive value creation across its network of 20 diagnostic imaging centres and 2 laboratory centres in Spain.

  • Buyer
    Apax Partners LLP, Fremman Capital
    Target
    Palex Medical
    Seller
    Funds advised by Fremman, Other minority shareholders
    Industry
    Medical Devices
    Location
    Catalonia, Spain

    Funds advised by Apax Partners LLP and funds advised by Fremman Capital agreed to acquire co-controlling stakes in Palex Medical, with Fremman remaining an investor while some of its funds and other minority shareholders sell. Palex, a Sant Cugat del Vallès (Barcelona)-headquartered MedTech distributor with ~928 employees, will partner with Apax and Fremman to accelerate pan-European growth and international expansion; the deal is expected to close in Q4 2023 and financial terms were not disclosed.

  • Buyer
    Fremman Capital
    Target
    Kids Planet Day Nurseries
    Seller
    BGF, Founding management (Clare Roberts and John Hoban)
    Industry
    Education
    Location
    England, United Kingdom
    Type
    Buyout

    Fremman Capital has acquired a majority stake in Kids Planet Day Nurseries, the UK's largest independently owned nursery operator. Founding management and BGF will remain as significant minority shareholders; the investment will fund accelerated national expansion, senior hires and recruitment across Kids Planet's 82 sites serving over 7,500 children.

  • Buyer
    Fremman (Fremman 1 MM SCSp)
    Target
    Palex
    Seller
    Ergon Capital Partners IV SCSp, Corpfin Capital
    Industry
    Medical Devices
    Location
    Catalonia, Spain
    Type
    Buyout

    Fremman has acquired a majority stake in Palex, the leading distributor of high value-added MedTech equipment and solutions in Spain and Portugal, from Ergon Capital Partners and Corpfin Capital. Management, Ergon and Corpfin will remain minority shareholders as Fremman partners with the Palex team to pursue further consolidation and geographic expansion across Iberia and Europe.

  • Buyer
    Fremman Capital, GPF Capital
    Target
    The Natural Fruit Company (TNFC)
    Seller
    Existing selling shareholders / family shareholders
    Industry
    Food & Beverage
    Location
    Spain
    Type
    Buyout

    Fremman Capital has closed the acquisition of a majority stake in The Natural Fruit Company (TNFC), a leading Spanish citrus processor and distributor, with GPF Capital remaining involved alongside existing shareholders. TNFC, which controls approximately 900 hectares of plantations and operates eight processing facilities (plus a logistics site in Perpignan, France), will pursue organic growth and an active M&A-driven consolidation strategy under Fremman's ownership; financial terms were not disclosed.

  • Buyer
    Fremman Capital
    Target
    VPS
    Location
    South Holland, Netherlands
    Type
    Buyout

    Fremman Capital has entered exclusive discussions to acquire a majority stake in VPS, a Rotterdam-headquartered marine fuel testing, inspection and advisory provider. Fremman said it will support VPS's management to expand its testing, data and ESG-focused advisory capabilities; debt financing for the intended transaction will be provided by Bridgepoint Credit and OLB.

Related Acquisition Pages

Selling a company? Get in front of buyers like Fremman Capital

Turn tracked acquisition activity into an outreach-ready buyer list.